Remove 2019 Remove Documentation Remove Packaging
article thumbnail

MSD secures full approval for Keytruda’s use in MSI-high solid tumours

Pharmaceutical Technology

There, the FDA suggested that the drugs undergo randomised controlled trials, which the document describes as the preferred approach, rather than single-arm trials. While the drug was granted accelerated approval in June 2019, it did not deliver on a key overall survival (OS) endpoint as part of its post-marketing data package.

article thumbnail

Omnicell and Fresenius Kabi Join Forces to Improve Controlled Substance Management

Omnicell

In 2019, more than 148 million doses of medicine were lost , endangering both patients and employees. And according to the 2019 Drug Diversion Digest , 47.2 Hospitals are already using Fresenius Kabi Simplist® MicroVault® prefilled syringes to help nurses spend less time preparing doses and documenting waste.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Mastering Responses to FDA 510(k) AI Letters: A Strategic Approach

The FDA Law Blog

Performance Metric FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 Average Number of FDA Days to MDUFA IV Decision 72.62 In this case, the FDA clock start date is determined as the date of receiving the submission by the Document Control Center (DCC). Attachment number) and document name or description as appropriate.

FDA 75
article thumbnail

Methodology to Define a Pharma 4.0™ Roadmap

ISPE

The key to data integrity compliance is a well-functioning data governance system 1 , 2 in which the data flow path for all business processes and equipment—such as in manufacturing, laboratory, and clinical studies—is fully understood and documented by a detailed process data flow map. Pharmaceutical Engineering (May/June 2019).

article thumbnail

From start to finish – digitising clinical trials

pharmaphorum

Thankfully, paper-based studies are becoming a thing of the past, but spreadsheets and Word documents are still commonly used to design and build trials. In 2019, Formedix collaborated with a UK-based consortium interested in observing early safety data. This gives great risk for human error and misinterpretation.

article thumbnail

Piloting the PQA Specialty Pharmacy Turnaround Time Quality Measure

PQA

From 2018-2019, PQA convened a multistakeholder Specialty Pharmacy Turnaround Time Task Force to develop specifications for the measure concept, focused on establishing a standardized measure of the time between a specialty pharmacy receiving a new prescription for a specialty medication and the product being available for the patient (i.e.,

article thumbnail

CMS Final Medicaid Drug Rebate Rule Details New Misclassification Penalties and Numerous Other Changes

The FDA Law Blog

Penalties for “Misclassification” The Medicaid Services Investment and Accountability Act of 2019 added new penalties to the Medicaid rebate statute for knowingly misclassifying a covered outpatient drug. The most noteworthy are the following: 1. See 42 U.S.C. 1396r-8(b)(3)(C)(iii).